BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12134421)

  • 1. [From effective to economical. The value of good osteoporosis therapy].
    Minne HW; Pfeifer M; Pollähne W
    MMW Fortschr Med; 2002 May; 144(21):30-3. PubMed ID: 12134421
    [No Abstract]   [Full Text] [Related]  

  • 2. [The necessity of cost-effectiveness analysis in osteoporosis].
    Lamy O; Krieg MA
    Rev Med Suisse; 2007 Jun; 3(115):1521-5. PubMed ID: 17682796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Osteoporosis treatment in Portugal: trends and geographical variation].
    Rocha O; Lunet N; Costa L; Barros H
    Acta Med Port; 2006; 19(5):373-80. PubMed ID: 17376323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of osteoporosis].
    Lakatos P
    Orv Hetil; 2003 Aug; 144(31):1551-2. PubMed ID: 14502870
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evidence-based assessment of therapeutic agents of osteoporosis. Bisphosphonates, SERM and basic therapy in front].
    MMW Fortschr Med; 2003 Jul; 145(27-28):63. PubMed ID: 14587198
    [No Abstract]   [Full Text] [Related]  

  • 6. [Osteoporosis - Evidence based therapy].
    Minne HW; Begerow B; Pfeifer M
    Z Gastroenterol; 2002 Apr; 40 Suppl 1():S57-S61. PubMed ID: 11930292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis guidelines.
    Laupacis A
    CMAJ; 2003 Jun; 168(13):1644-5; author reply 1645-6. PubMed ID: 12821610
    [No Abstract]   [Full Text] [Related]  

  • 8. Drugs for prevention and treatment of postmenopausal osteoporosis.
    Treat Guidel Med Lett; 2002 Nov; 1(3):13-8. PubMed ID: 15529101
    [No Abstract]   [Full Text] [Related]  

  • 9. The search for good compliance: economic aspects of a conveyed combination pharmaco-therapy, exemplified by an osteoporosis therapy.
    Oberender P; Zerth J
    Eur J Health Econ; 2008 May; 9(2):127-36. PubMed ID: 17447094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug treatment for the treatment of primary osteoporosis].
    Halbekath J
    Z Arztl Fortbild Qualitatssich; 2000 Aug; 94(6):453-60. PubMed ID: 10996934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of osteoporosis in Hong Kong.
    Kung AW
    Clin Calcium; 2004 Sep; 14(9):108-11. PubMed ID: 15577121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic considerations on secondary osteoporosis caused by diabetes mellitus].
    Azuma K
    Clin Calcium; 2009 Sep; 19(9):1345-52. PubMed ID: 19721208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [First choice drug for treatment of osteoporosis and the strategic points for choice of drugs].
    Soen S
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():325-8. PubMed ID: 18159713
    [No Abstract]   [Full Text] [Related]  

  • 14. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, March 7-29, 2000: highlights of the conference.
    South Med J; 2001 Jun; 94(6):569-73. PubMed ID: 11440324
    [No Abstract]   [Full Text] [Related]  

  • 15. [Osteoporosis therapy compared. More solid bones with bisphosphonates].
    MMW Fortschr Med; 2003 Aug; 145(31-32):55. PubMed ID: 14524081
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnosis and therapy of osteoporosis. Strategy for effective treatment after fragility fractures].
    Bartl R; Bartl C; Mutschler W
    Unfallchirurg; 2003 Jul; 106(7):526-41. PubMed ID: 12883779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoporosis: overview in disease, epidemiology, treatment and health economy.
    Pongchaiyakul C; Songpattanasilp T; Taechakraichana N
    J Med Assoc Thai; 2008 Apr; 91(4):581-94. PubMed ID: 18556872
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of the cost of non-hormonal treatment of osteoporosis].
    Peretz A
    Rev Med Brux; 1998 Sep; 19(4):A204-7. PubMed ID: 9805945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary on Mobley and Others: importance of assumptions about VTE mortality in modeling the cost-effectiveness of osteoporosis therapies.
    Meadows ES; Stock J; Johnston JA
    Med Decis Making; 2006; 26(6):633-5; author reply 636-7. PubMed ID: 17099202
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of different treatments for osteoporosis on prevention of fractures: toward and individualized and economic approach].
    Lamy O; Krieg MA
    Praxis (Bern 1994); 2004 Mar; 93(11):399-405. PubMed ID: 15061107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.